55
Participants
Start Date
June 2, 2020
Primary Completion Date
May 24, 2024
Study Completion Date
December 5, 2024
Gemcitabine
800 mg/m2 Day 1, 8, 15: Q4W IV Infusion
Nab-paclitaxel
100 mg/m2 Day 1, 8, 15: Q4W IV Infusion
Nivolumab
3 mg/kg Day 1, Q4W IV Infusion
Ipilimumab
1 mg/kg Day 1 Cycle 1 IV Infusion
SBRT
"Patients will be planned and treated with SBRT on a MRidian MR guided Linac.~Prescription dose shall be according to the following specifications:~* Prescription dose shall be according to the following specifications:~* A total dose of 24 Gy in 3 fractions (3 fractions/week) are prescribed as the mean dose to the PTV.~* Pauses are accepted but the treatment should be delivered within 10 calendar days.~* PTV should be covered by 95% isodose (PTV D99% \>95%)."
Herlev & Gentofte University Hospital, Denmark, Herlev
Herlev Hospital
OTHER